A comprehensive 24-page patient support brochure developed for Omnitrope (somatropin), a Sandoz biosimilar human growth hormone therapy used in the treatment of growth hormone deficiency and related growth disorders in children and adults. The brochure is designed to educate patients and caregivers about treatment pathways, administration guidance, therapy adherence, and long-term growth management in a clear and supportive format. Omnitrope contains somatropin, a recombinant human growth hormone used for conditions associated with impaired growth and growth hormone deficiency.

Leadtime:

• Production: 4-6 working days
• Delivery 3-6 working days